227 related articles for article (PubMed ID: 20508216)
1. Alpha-galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infection.
Sada-Ovalle I; Sköld M; Tian T; Besra GS; Behar SM
Am J Respir Crit Care Med; 2010 Sep; 182(6):841-7. PubMed ID: 20508216
[TBL] [Abstract][Full Text] [Related]
2. Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria.
Sada-Ovalle I; Chiba A; Gonzales A; Brenner MB; Behar SM
PLoS Pathog; 2008 Dec; 4(12):e1000239. PubMed ID: 19079582
[TBL] [Abstract][Full Text] [Related]
3. Quantitative and qualitative iNKT repertoire associations with disease susceptibility and outcome in macaque tuberculosis infection.
Chancellor A; White A; Tocheva AS; Fenn JR; Dennis M; Tezera L; Singhania A; Elliott T; Tebruegge M; Elkington P; Gadola S; Sharpe S; Mansour S
Tuberculosis (Edinb); 2017 Jul; 105():86-95. PubMed ID: 28610792
[TBL] [Abstract][Full Text] [Related]
4. Structure-Function Implications of the Ability of Monoclonal Antibodies Against α-Galactosylceramide-CD1d Complex to Recognize β-Mannosylceramide Presentation by CD1d.
Clark K; Yau J; Bloom A; Wang J; Venzon DJ; Suzuki M; Pasquet L; Compton BJ; Cardell SL; Porcelli SA; Painter GF; Zajonc DM; Berzofsky JA; Terabe M
Front Immunol; 2019; 10():2355. PubMed ID: 31649670
[TBL] [Abstract][Full Text] [Related]
5. Imaging α-GalCer-Activated iNKT Cells in a Hepatic Metastatic Environment.
Babes L; Shim R; Kubes P
Cancer Immunol Res; 2022 Jan; 10(1):12-25. PubMed ID: 34785505
[TBL] [Abstract][Full Text] [Related]
6. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic Treatment Shapes the Antigenic Environment During Chronic TB Infection, Offering Novel Targets for Therapeutic Vaccination.
Chuang YM; Dutta NK; Gordy JT; Campodónico VL; Pinn ML; Markham RB; Hung CF; Karakousis PC
Front Immunol; 2020; 11():680. PubMed ID: 32411131
[TBL] [Abstract][Full Text] [Related]
8. α-galactosylceramide generates lung regulatory T cells through the activated natural killer T cells in mice.
Chen Q; Guo X; Deng N; Liu L; Chen S; Wang A; Li R; Huang Y; Ding X; Yu H; Hu S; Nie H
J Cell Mol Med; 2019 Feb; 23(2):1072-1085. PubMed ID: 30421497
[TBL] [Abstract][Full Text] [Related]
9. Natural Killer T-Cell Agonist α-Galactosylceramide and PD-1 Blockade Synergize to Reduce Tumor Development in a Preclinical Model of Colon Cancer.
Wang Y; Bhave MS; Yagita H; Cardell SL
Front Immunol; 2020; 11():581301. PubMed ID: 33193386
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory Functions of α-GalCer and a Derivative, α-Carba-GalCer.
Satoh M; Iwabuchi K
Methods Mol Biol; 2023; 2613():1-11. PubMed ID: 36587066
[TBL] [Abstract][Full Text] [Related]
11. Dissociated expression of natural killer 1.1 and T-cell receptor by invariant natural killer T cells after interleukin-12 receptor and T-cell receptor signalling.
Emoto M; Shimizu T; Koike H; Yoshizawa I; Hurwitz R; Kaufmann SH; Emoto Y
Immunology; 2010 Jan; 129(1):62-74. PubMed ID: 20028429
[TBL] [Abstract][Full Text] [Related]
12. Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.
Hung JT; Huang JR; Yu AL
J Biomed Sci; 2017 Mar; 24(1):22. PubMed ID: 28335781
[TBL] [Abstract][Full Text] [Related]
13. α-Galactosylceramide treatment before allergen sensitization promotes iNKT cell-mediated induction of Treg cells, preventing Th2 cell responses in murine asthma.
Chen Q; Guo X; Deng N; Liu L; Chen S; Wang A; Li R; Huang Y; Ding X; Yu H; Hu S; Nie H
J Biol Chem; 2019 Apr; 294(14):5438-5455. PubMed ID: 30745361
[TBL] [Abstract][Full Text] [Related]
14. Decreased expressions of CD1d molecule on liver dendritic cells in subcutaneous tumor bearing mice.
Tatsumi T; Takehara T; Yamaguchi S; Sasakawa A; Yamamoto M; Fujita Y; Miyagi T; Ohkawa K; Hayashi N
J Hepatol; 2008 Nov; 49(5):779-86. PubMed ID: 18760855
[TBL] [Abstract][Full Text] [Related]
15. Non-glycosidic compounds can stimulate both human and mouse iNKT cells.
Jukes JP; Gileadi U; Ghadbane H; Yu TF; Shepherd D; Cox LR; Besra GS; Cerundolo V
Eur J Immunol; 2016 May; 46(5):1224-34. PubMed ID: 26873393
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Berberine as an Adjunct to TB Treatment.
Ozturk M; Chia JE; Hazra R; Saqib M; Maine RA; Guler R; Suzuki H; Mishra BB; Brombacher F; Parihar SP
Front Immunol; 2021; 12():656419. PubMed ID: 34745081
[TBL] [Abstract][Full Text] [Related]
17. α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials.
Zhang Y; Springfield R; Chen S; Li X; Feng X; Moshirian R; Yang R; Yuan W
Front Immunol; 2019; 10():1126. PubMed ID: 31244823
[TBL] [Abstract][Full Text] [Related]
18. Exogenous Activation of Invariant Natural Killer T Cells by α-Galactosylceramide Reduces Pneumococcal Outgrowth and Dissemination Postinfluenza.
Barthelemy A; Ivanov S; Hassane M; Fontaine J; Heurtault B; Frisch B; Faveeuw C; Paget C; Trottein F
mBio; 2016 Nov; 7(6):. PubMed ID: 27803187
[TBL] [Abstract][Full Text] [Related]
19. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8
Ghnewa YG; O'Reilly VP; Vandenberghe E; Browne PV; McElligott AM; Doherty DG
Clin Immunol; 2017 Oct; 183():91-98. PubMed ID: 28780376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
